Advertisement

Topics

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

18:41 EDT 20 Mar 2017 | News-Medical.net

Three-quarters of all breast cancer tumors are driven by the hormone estrogen. These tumors are frequently treated with drugs to suppress estrogen receptor activity, but unfortunately, at least half of patients do not respond to these treatments, leaving them with drug-resistant tumors and few options.

Original Article: Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

NEXT ARTICLE

More From BioPortfolio on "Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers"

Quick Search
Advertisement
 

Relevant Topics

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...